2,155
Views
1
CrossRef citations to date
0
Altmetric
Author's Views

Ewing sarcoma fusion oncogene: At the crossroads of transcription and DNA damage response

ORCID Icon & ORCID Icon
Article: e1465014 | Received 02 Apr 2018, Accepted 03 Apr 2018, Published online: 29 May 2018
 

Financial disclosures

None

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Acknowledgments

This work was supported by funds from NIH (K22ES012264, 1R15ES019128, 1R01CA152063), Voelcker Fund Young Investigator Award and CPRIT (RP150445) to A.J.R.B.; CPRIT (RP101491), Translational Science Training Across Disciplines Scholarship (UTHSA) and NCI postdoctoral training grant (T32CA148724) to A.G.

Additional information

Funding

HHS | NIH | National Cancer Institute (NCI) (1R01CA152063) Voelcker Fund Young Investigator Award Cancer Prevention and Research Institute of Texas (CPRIT) (RP150445) HHS | NIH | National Cancer Institute (NCI) (5T32CA148724-2) Cancer Prevention and Research Institute of Texas (CPRIT) (RP101491) Translational Science Training Across Disciplines Scholarship HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) (1R15ES019128) HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) (K22ES012264).